Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?-Reference-Cited by-同舟云学术

Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?

Published:2022-07 Issue:7 Volume:34 Page:452-458
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Jaishankar S.,Pifer P.M.^ORCID,Bhargava R.,Keller A.,Musunuru H.B.,Patel A.K.^ORCID,Sukumvanich P.,Boisen M.,Berger J.L.,Taylor S.,Courtney-Brooks M.,Olawaiye A.,Lesnock J.,Edwards R.,Vargo J.A.,Beriwal S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference17 articles.

1. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality;O'Brien;Br J Obstet Gynaecol,2009

2. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer;Vaizoglu;Arch Gynecol Obstet,2013

3. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – a pooled analysis of PORTEC 1 and 2 trials;Bosse;Eur J Cancer,2015

4. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - a single-institution study;Pifer;Gynecol Oncol,2020

5. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers;Hamilton;Br J Cancer,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological outcomes of minimally invasive surgery in non-endometrioid endometrial Cancer patients with varying prognostic risks: a retrospective cohort study based on the ESGO/ESTRO/ESP 2020 guidelines;BMC Surgery;2024-09-10

2. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: A systematic review and meta-analysis;Gynecologic Oncology;2024-05

3. An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma;Scientific Reports;2024-03-11

4. A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer;Clinical Oncology;2023-09

5. A Risk-scoring Model for Predicting Post-recurrence Survival in Patients With Endometrial Carcinoma;Clinical Oncology;2023-07